FierceDrugDelivery Archives - World Asthma Foundation

September 21, 2015

FDA expands indication of BI inhaler to include maintenance treatment of asthma – FierceDrugDelivery

FDA expands indication of BI inhaler to include maintenance treatment of asthma
FierceDrugDelivery
The only inhaler that administers a slow-moving mist to help respiratory patients inhale the medication is now FDA-approved for the long-term maintenance treatment of asthma, in addition to its previous indication to treat COPD. The expanded indication …
FDA Approves New Indication for Boehringer's Spiriva RespimatDrug Discovery & Development
Landmark year for Boehringer Ingelheim's respiratory portfolio – new data for …The FINANCIAL
ERS 2015: Landmark year for Boehringer Ingelheim's respiratory portfolio – new …Business Wire (press release)

all 15 news articles »

View full post on asthma – Google News

February 26, 2014

Teva snags an EU recommendation for its asthma, COPD inhaler – FierceDrugDelivery

Teva snags an EU recommendation for its asthma, COPD inhaler
FierceDrugDelivery
European regulatory authorities gave Teva ($TEVA) a positive opinion for its DuoResp Spiromax inhalation powder, designed to treat asthma and chronic obstructive pulmonary disease (COPD). With the recommendation from the Committee for Medicinal …

View full post on asthma – Google News

January 4, 2012

New year brings new delay for SkyePharma’s Flutiform asthma inhaler – FierceDrugDelivery

New year brings new delay for SkyePharma's Flutiform asthma inhaler
FierceDrugDelivery
That's because the British drug delivery company now stands to face an additional delay of between 6 and 9 months in the approval process for its Flutiform asthma therapy. As Reuters and the UK's The Telegraph reported just before the holidays, …

View full post on asthma – Google News